Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Abortion Access and Pregnancy Dangers Continue

    This issue will look at some of the repercussions of the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization and hear from providers and researchers on what can be done to mitigate the damage to their patients’ health and lives.

  • Treatment Direction After Unsuccessful Attempts at Smoking Cessation

    This randomized trial found that, for patients unable to stop smoking after six weeks of treatment, increasing the dose of either varenicline or combination nicotine replacement therapy (CNRT) or switching from CNRT to varenicline, leads to an increased likelihood of success.

  • Blood Biomarker for the Diagnosis of Alzheimer’s Disease

    In this population-based study of patients in Sweden with cognitive complaints, mild cognitive impairment, and dementia, the use of blood biomarkers, specifically, phosphorylated tau 217 and amyloid-beta 42/40 ratios, improved the diagnostic accuracy for pathological Alzheimer’s disease in primary care patients as well as patients seen by dementia specialists.

  • Metformin Reduces SARS-CoV-2 Viral Load in Outpatients with COVID-19

    A randomized, placebo-controlled clinical trial of outpatients with COVID-19 found that metformin reduced SARS-CoV-2 viral load 3.6-fold compared to placebo, while ivermectin and fluvoxamine showed no benefit.

  • Lebrikizumab-lbkz Injection (Ebglyss)

    The U.S. Food and Drug Administration has approved a humanized monoclonal antibody that targets interleukin-13 for the treatment of moderate-to-severe atopic dermatitis.

  • Diagnostic Uncertainty in Community-Acquired Pneumonia

    A national retrospective cohort study from the Veterans Administration found a high rate of diagnostic discordance for patients admitted and discharged for community-acquired pneumonia (CAP). Improvement in the diagnosis of CAP is needed.

  • Understanding Myocarditis, COVID-19 Infection, and COVID-19 Vaccines

    Although myocarditis is rare, interest has increased in recent years because of the COVID-19 pandemic and COVID-19 vaccinations both being associated with its development. This review article will trace the history of myocarditis from the pre-COVID-19 era to the present day.

  • A Review of Throat Infections: Low-Acuity Disease

    Sore throats are common pediatric chief complaints, with etiologies ranging from thrush to epiglottitis. All clinicians must be familiar with the diversity of causes from benign to life-threatening in order to decrease morbidity and mortality with a timely diagnosis.

  • Pediatric Trauma 2025 Is Here!

    The latest installment in an award-winning series, Pediatric Trauma 2025: Quality Care for Serious Pediatric Injuries facilitates excellence by covering the latest scientific information on caring for children who present with traumatic injuries. Perfect for pediatric trauma programs, this book provides 18 hours of pediatric trauma-specific CME/CE credits, meeting the yearly requirements for trauma-certified professionals.

  • Eculizumab for Treating Aquaporin-4 Antibody-Positive NMOSD

    In this retrospective study of a cohort of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) patients treated with eculizumab, the authors reported efficacy with decreasing relapse rate, magnetic resonance imaging changes, and disability outcomes, but cautioned about the risk of serious infections.